ArticleFrontiers in medicine2025
Clinical characteristics and prognosis of non-typhoidal
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genomic and plasmid profiles of multidrug-resistantMicrobiology spectrum · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Several studies have reported the clinical characteristics of non-typhoidal Salmonella (NTS) bacteremia in children and adults. However, there is a lack of data that directly compares the clinical characteristics and prognosis in children vs. adults. Methods: A retrospective study was conducted on bloodstream infections caused by NTS in hospitalized patients from 1 January 2018 to 31 December 2024. The clinical and relevant laboratory data of patients between adult and pediatric groups were compared, and the risk factors predicting the duration of antibiotic treatment were analyzed by multivariate logistic regression. Results: In total, 52 patients with NTS bloodstream infection met the eligibility criteria, with 28 (53.8%) being children vs. 24 (46.2%) adults. Respiratory infections are the most concomitant diseases (children 78.6% vs. adults 50.0%, Conclusion: A shorter course of antibiotic treatment was observed in pediatric patients; however, due to its biases and limitations, further prospective randomized controlled trials are needed to generalize our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.